BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12150364)

  • 1. Hyperlipidemia in Native Americans: evaluation of lipid management through a cardiovascular risk reduction program.
    Burden RW; Kumar RN; Phillips DL; Borrego ME; Galloway JM
    J Am Pharm Assoc (Wash); 2002; 42(4):652-5. PubMed ID: 12150364
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid analysis in an aging population.
    Pallazola VA; Sathiyakumar V; Martin SS
    Aging (Albany NY); 2019 Feb; 11(4):1073-1074. PubMed ID: 30733425
    [No Abstract]   [Full Text] [Related]  

  • 3. PCSK9 inhibition - a novel mechanism to treat lipid disorders?
    Banach M; Rizzo M; Obradovic M; Montalto G; Rysz J; Mikhailidis DP; Isenovic ER
    Curr Pharm Des; 2013; 19(21):3869-77. PubMed ID: 23286435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperlipidaemia and cardiovascular disease.
    Buchalter M
    Curr Opin Lipidol; 1997 Jun; 8(3):U40-1. PubMed ID: 9211073
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pleiotropic effects of fibrates].
    Okopień B; Łebek M; Herman ZS
    Pol Arch Med Wewn; 2001 Dec; 106(6):1187-91. PubMed ID: 12026540
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond statins: what to expect from add-on lipid regulating therapy?
    Laufs U; Weintraub WS; Packard CJ
    Eur Heart J; 2013 Sep; 34(34):2660-5. PubMed ID: 23832488
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipids and cardiovascular diseases.
    Sniderman AD; Frohlich J
    Can J Cardiol; 1999 Dec; 15 Suppl G():51G-6G. PubMed ID: 10692659
    [No Abstract]   [Full Text] [Related]  

  • 8. Reaching low density lipoprotein cholesterol targets.
    Rizos CV; Barkas F; Elisaf MS
    Curr Med Res Opin; 2014 Oct; 30(10):1967-9. PubMed ID: 25055191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case for lipid-lowering?
    Durrington P
    Diabet Med; 2000 Sep; 17 Suppl 2():4-5. PubMed ID: 11048824
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of a lipid lowering fibrate and hormone replacement therapy on serum lipids and lipoproteins in overweight postmenopausal women with elevated triglycerides.
    Nerbrand C; Nyberg P; Nordström L; Samsioe G
    Maturitas; 2002 May; 42(1):55-62. PubMed ID: 12020980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of cardiovascular events in patients at optimal values for combined lipid parameters.
    Stanek EJ; Sarawate C; Willey VJ; Charland SL; Cziraky MJ
    Curr Med Res Opin; 2007 Mar; 23(3):553-63. PubMed ID: 17357251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Update: clinical lipidology].
    Parhofer KG
    MMW Fortschr Med; 2013 Jul; 155(13):49-52; quiz 53-4. PubMed ID: 23964509
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of natural phytosterins for correction of abnormalities of lipid metabolism].
    Pogozheva AV
    Kardiologiia; 2011; 51(5):75-80. PubMed ID: 21649598
    [No Abstract]   [Full Text] [Related]  

  • 14. Nutraceuticals and functional foods in the management of hyperlipidemia.
    Chen G; Wang H; Zhang X; Yang ST
    Crit Rev Food Sci Nutr; 2014; 54(9):1180-201. PubMed ID: 24499150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlipidaemia and cardiovascular disease.
    Stone NJ
    Curr Opin Lipidol; 2001 Dec; 12(6):667-9. PubMed ID: 11801867
    [No Abstract]   [Full Text] [Related]  

  • 16. Options for the treatment of hyperlipidemia in Type 2 diabetes mellitus and hypothyroidism: lowering the cardiovascular risk.
    Duntas L; Kolovou G
    Future Cardiol; 2011 Mar; 7(2):137-44. PubMed ID: 21453018
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular risk modification in childhood: hyperlipidemia.
    Weidman WH
    Mayo Clin Proc; 1986 Nov; 61(11):910-3. PubMed ID: 3762230
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid lowering for primary prevention.
    Yusuf S; Lonn E; Bosch J
    Lancet; 2009 Apr; 373(9670):1152-5. PubMed ID: 19345816
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: reducing cardiovascular risk: is low-density lipoprotein-cholesterol (LDL-C) lowering enough?
    Kostapanos MS; Katsiki N; Elisaf MS; Mikhailidis DP
    Curr Vasc Pharmacol; 2012 Mar; 10(2):173-7. PubMed ID: 22250844
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in the management of hyperlipidemia-induced atherosclerosis.
    Tannock LR
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):369-83. PubMed ID: 18327996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.